ロード中...
Secukinumab for ankylosing spondylitis and psoriatic arthritis
The treatment of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) positively changed since the introduction of anti-TNFα drugs. These treatments were shown to reduce the symptoms and signs of the diseases and improve the quality of life. However, a variable percentage of patients do not res...
保存先:
| 出版年: | Ther Clin Risk Manag |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5085310/ https://ncbi.nlm.nih.gov/pubmed/27799780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S100091 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|